Search
for
Sort by
Research 931–960 of 1000+
- Clinical and pathological evaluation of hemp seeds oil effectiveness in the treatment of alopecia areata
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target
- Alopecia Areata in a Dog: Clinical, Dermoscopic and Histological Features
- Use of Lasers in the Treatment of Alopecia Areata
- What’s New in the Histologic Evaluation of Alopecia and Hair-Related Disorders?
- Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study
- The Multi-Faceted Role of Gut Microbiota in Alopecia Areata
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Alopecia Areata and malignancies: uncertainties clarified by a large-scale population-based study
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study
- Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters
- RETRACTED: Genetic association between asthma and alopecia areata: A two‐sample Mendelian randomization study
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Platelet-rich plasma in the treatment of alopecia areata: A retrospective evaluation of 17 patients
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- A Potential Predictive Role of the Scalp Microbiome Profiling in Patients with Alopecia Areata: Staphylococcus caprae, Corynebacterium, and Cutibacterium Species
- Association Between Vitamin D and Zinc Levels With Alopecia Areata Phenotypes at a Tertiary Care Center
- Alopecia y microbioma: ¿futura diana terapéutica?
- The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review
- Cutaneous Mastocytosis Associated With Congenital Alopecia
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data